New Zealand markets closed

Takeda Pharmaceutical Company Limited (TKPHF)

OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD
Add to watchlist
26.06-0.23 (-0.87%)
At close: 12:50PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 41.31B
Enterprise value 69.15B
Trailing P/E 44.80
Forward P/E 16.56
PEG ratio (5-yr expected) 0.56
Price/sales (ttm)1.51
Price/book (mrq)0.88
Enterprise value/revenue 2.55
Enterprise value/EBITDA 10.85

Trading information

Stock price history

Beta (5Y monthly) 0.54
52-week change 3-18.89%
S&P500 52-week change 326.14%
52-week high 332.76
52-week low 325.04
50-day moving average 326.88
200-day moving average 328.53

Share statistics

Avg vol (3-month) 38.37k
Avg vol (10-day) 32.42k
Shares outstanding 51.57B
Implied shares outstanding 61.59B
Float 81.55B
% held by insiders 10.03%
% held by institutions 144.94%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 41.26
Forward annual dividend yield 44.84%
Trailing annual dividend rate 3188.00
Trailing annual dividend yield 3715.10%
5-year average dividend yield 44.58
Payout ratio 4206.23%
Dividend date 328 Jun 2010
Ex-dividend date 427 Sept 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in JPY.

Fiscal year

Fiscal year ends 31 Mar 2024
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 3.38%
Operating margin (ttm)-7.40%

Management effectiveness

Return on assets (ttm)1.57%
Return on equity (ttm)2.12%

Income statement

Revenue (ttm)4.26T
Revenue per share (ttm)2,725.41
Quarterly revenue growth (yoy)9.90%
Gross profit (ttm)N/A
EBITDA 1.09T
Net income avi to common (ttm)144.07B
Diluted EPS (ttm)0.58
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)457.8B
Total cash per share (mrq)291.78
Total debt (mrq)5.53T
Total debt/equity (mrq)76.05%
Current ratio (mrq)1.11
Book value per share (mrq)4,635.56

Cash flow statement

Operating cash flow (ttm)716.34B
Levered free cash flow (ttm)35.08B